Relapse · patients with schizophrenia
COMPARISON 1: CBT+ STANDARD CARE showed no clear difference in global state: 1a. Relapse ‐ long term compared with STANDARD CARE ALONE (low certainty).
1 finding from 1 review
Relapse · people with severe mental disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · people with severe mental disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · patients with schizophrenia
1 finding from 1 review
Relapse · patients with schizophrenia
1 finding from 1 review
Relapse · patients with schizophrenia
1 finding from 1 review
Relapse · patients with schizophrenia
1 finding from 1 review
Relapse · patients with schizophrenia
1 finding from 1 review
Global state: Relapse ‐ long term ‐ not measured · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether ORAL FLUPHENAZINE changes global state: Relapse ‐ long termClinical judgement compared with PLACEBO (very low certainty).
1 finding from 1 review
Global state: relapse ‐ medium term ‐ not measured · patients with schizophrenia
BRIEF FAMILY INTERVENTION showed no clear difference in global state ‐ relapse ‐ medium to long term relapse rates (clinical… compared with STANDARD CARE (low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes global state: Relapse (any reason) ‐ long term Number of… compared with GENERAL ORAL ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
RISPERIDONE DEPOT showed no clear difference in global state: Relapse (any reason) ‐ long term Assessed by 5 blinded… compared with ORAL ARIPIPRAZOLE (low certainty).
1 finding from 1 review